TERPA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
TERPA
Largest movements
- Receivables within one year +€828
up €828 (+5.6%), from €14,709 to €15,537
of which Other amounts receivable: +€828
- Other debts +€2,166
up €2,166 (+2.3%), from €94,633 to €96,799
- Profit (loss) carried forward -€974
down €974 (-1.5%), from -€64,326 to -€65,300
- Gross operating margin -€1,207
down €1,207, from €276 to -€931
- Other operating charges -€963
no longer reported in 2025 (was €963)
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €74,155 | €74,798 | +€643 | +0.9% |
| Fixed assets | 21/28 | €41,655 | €41,655 | = | 0.0% |
| Tangible fixed assets | 22/27 | €41,655 | €41,655 | = | 0.0% |
| Other tangible fixed assets | 26 | €41,655 | €41,655 | = | 0.0% |
| Current assets | 29/58 | €32,500 | €33,142 | +€643 | +2.0% |
| Amounts receivable after more than one year | 29 | €17,500 | €17,000 | -€500 | -2.9% |
| Other amounts receivable | 291 | €17,500 | €17,000 | -€500 | -2.9% |
| Amounts receivable within one year | 40/41 | €14,709 | €15,537 | +€828 | +5.6% |
| Trade receivables | 40 | €10,551 | €10,551 | = | 0.0% |
| Other amounts receivable | 41 | €4,158 | €4,986 | +€828 | +19.9% |
| Cash at bank and in hand | 54/58 | €291 | €606 | +€315 | +108% |
| Total equity and liabilities | 10/49 | €74,155 | €74,798 | +€643 | +0.9% |
| Equity | 10/15 | -€39,396 | -€40,370 | -€974 | -2.5% |
| Contributions | 10/11 | €18,592 | €18,592 | = | 0.0% |
| Reserves | 13 | €6,338 | €6,338 | = | 0.0% |
| Non-distributable reserves | 130/1 | €1,859 | €1,859 | = | 0.0% |
| Reserves not available under the articles | 1311 | €1,859 | €1,859 | = | 0.0% |
| Tax-exempt reserves | 132 | €4,479 | €4,479 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€64,326 | -€65,300 | -€974 | -1.5% |
| Amounts payable | 17/49 | €113,551 | €115,167 | +€1,616 | +1.4% |
| Amounts payable within one year | 42/48 | €96,051 | €98,167 | +€2,116 | +2.2% |
| Trade debts | 44 | €367 | €381 | +€15 | +4.0% |
| Suppliers | 440/4 | €367 | €381 | +€15 | +4.0% |
| Taxes, remuneration and social security | 45 | €1,051 | €987 | -€64 | -6.1% |
| Taxes | 450/3 | €1,051 | €987 | -€64 | -6.1% |
| Other amounts payable | 47/48 | €94,633 | €96,799 | +€2,166 | +2.3% |
| Accrued charges and deferred income | 492/3 | €17,500 | €17,000 | -€500 | -2.9% |
| Other operating charges | 640/8 | €963 | - | -€963 | |
| Gross operating margin | 9900 | €276 | -€931 | -€1,207 | |
| Operating profit (loss) | 9901 | -€687 | -€931 | -€244 | -35.4% |
| Financial income | 75/76B | - | €2 | +€2 | |
| Recurring financial income | 75 | - | €2 | +€2 | |
| Financial charges | 65/66B | €45 | €45 | = | 0.0% |
| Recurring financial charges | 65 | €45 | €45 | = | 0.0% |
| Profit (loss) for the period before taxes | 9903 | -€732 | -€974 | -€242 | -33.0% |
| Profit (loss) for the period | 9904 | -€732 | -€974 | -€242 | -33.0% |
| Profit (loss) for the period to be appropriated | 9905 | -€732 | -€974 | -€242 | -33.0% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 14 October 2026 via checked.be.